|
π
|
Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis
12 auth.
J. Collet,
Y. Allali,
C. Lesty,
M. Tanguy,
J. Silvain,
A. Ankri,
...
B. Blanchet,
R. Dumaine,
J. Gianetti,
L. Payot,
J. Weisel,
G. Montalescot
|
8 |
2006 |
8
π
|
|
π
|
Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial.
15 auth.
G. Montalescot,
F. Philippe,
A. Ankri,
E. Vicaut,
E. Bearez,
J. Poulard,
D. CarriΓ©,
D. Flammang,
Albert Dutoit,
A. Carayon,
...
C. Jardel,
M. Chevrot,
J. Bastard,
F. Bigonzi,
Daniel Thomas
|
8 |
1998 |
8
π
|
|
π
|
Percutaneous Coronary Intervention After Subcutaneous Enoxaparin Pretreatment in Patients With Unstable Angina Pectoris
8 auth.
J. Collet,
G. Montalescot,
L. Lison,
R. Choussat,
A. Ankri,
G. Drobinski,
...
I. Sotirov,
Daniel Thomas
|
7 |
2001 |
7
π
|
|
π¬
|
Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery
P. Toulon,
Y. Ozier,
A. Ankri,
M. FlΓ©ron,
G. Leroux,
C. Samama
|
7 |
2009 |
7
π¬
|
|
π
|
Acute Release of Plasminogen Activator Inhibitor-1 in ST-Segment Elevation Myocardial Infarction Predicts Mortality
11 auth.
J. Collet,
G. Montalescot,
E. Vicaut,
A. Ankri,
F. Walylo,
C. Lesty,
...
R. Choussat,
F. Beygui,
M. Borentain,
N. Vignolles,
Daniel Thomas
|
7 |
2003 |
7
π
|
|
π¬
|
Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
R. Chadarevian,
EΜric Bruckert,
L. Leenhardt,
Philippe Giral,
A. Ankri,
G. Turpin
|
7 |
2001 |
7
π¬
|
|
π
|
Anti-Xa Activity Relates to Survival and Efficacy in Unselected Acute Coronary Syndrome Patients Treated With Enoxaparin
10 auth.
G. Montalescot,
J. Collet,
M. Tanguy,
A. Ankri,
L. Payot,
R. Dumaine,
...
R. Choussat,
F. Beygui,
Vanessa Gallois,
Daniel Thomas
|
7 |
2004 |
7
π
|
|
π
|
Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina.
10 auth.
G. Montalescot,
J. Collet,
L. Lison,
R. Choussat,
A. Ankri,
E. Vicaut,
...
K. Perlemuter,
F. Philippe,
G. Drobinski,
Daniel Thomas
|
7 |
2000 |
7
π
|
|
π
|
A unique, low dose of intravenous enoxaparin in elective percutaneous coronary intervention.
9 auth.
R. Choussat,
G. Montalescot,
J. Collet,
E. Vicaut,
A. Ankri,
Vanessa Gallois,
...
G. Drobinski,
I. Sotirov,
Daniel Thomas
|
7 |
2002 |
7
π
|
|
π¬
|
Fibrinogen after coronary angioplasty as a risk factor for restenosis.
G. Montalescot,
A. Ankri,
E. Vicaut,
G. Drobinski,
Y. Grosgogeat,
Daniel Thomas
|
6 |
1995 |
6
π¬
|
